The short version
Fifty 410 is a flat-rate telehealth provider. As of the August 25, 2026 build, for tirzepatide its lowest 12-month all-in total is $3,090 (month-to-month plan, verified), which places it 15 of 30 ranked telehealth providers; for semaglutide its lowest 12-month all-in total is $2,388 (month-to-month plan, verified), which places it 9 of 13 ranked telehealth providers. Verification status: verified.
The numbers, plan by plan
- Semaglutide (standard, injection, month-to-month plan): $199 per month. Status: verified, checked August 25, 2026. Semaglutide $199 monthly.
- Tirzepatide (standard, injection, month-to-month plan): $299 per month after an introductory $133 per month for the first 3 months (the price at higher doses is not published). Status: verified, checked August 25, 2026. Four-week option about $299; a three-month starter total of $399 ($133 per month equivalent) applies to first-time patients, and higher-dose bundles are priced separately.
Fees and what the price includes
The published price includes the medication and clinical care and shipping, with no separate membership fee. Shipping is included. The clinician consultation is included. The medication price rises with dose, so our 12-month total uses the titration model described on the methodology page.
How this pricing structure plays out over a year
The first 3 months cost $133 all-in; from month 4 the recurring cost is $299 a month, so the advertised $133 covers 13% of the first year's spend and the recurring price covers the rest. The price at 10 and 15 mg is not published. Most patients reach those doses by month six, so the twelve-month total shown assumes the starting price holds and is a floor, not a quote.
Compared with the field
On tirzepatide, Fifty 410's lowest twelve-month total of $3,090 is $1,590 above the lowest (Trimi, $1,500) and above the median of $3,090 across 30 ranked providers, placing it 15 of 30. On the value score it scores 62 against 92 for NexLife, the best-scoring provider; the gap comes from cost, transparency, care. On semaglutide, Fifty 410's lowest twelve-month total of $2,388 is $1,332 above the lowest (Sunlight, $1,056) and above the median of $2,100 across 13 ranked providers, placing it 9 of 13. On the value score it scores 62 against 92 for NexLife, the best-scoring provider; the gap comes from cost, transparency, care.
Pharmacy, coverage and cancellation
A complete list of states served has not been published; confirm eligibility at checkout before paying. Dispensing: 503A (provider-stated). Named pharmacies: ProRx, BPI / The Pharmacy Hub. Commitment: month-to-month; prepay discounts offered. Cancellation: Cancel anytime.
Questions to ask Fifty 410 before paying
Ask, in writing: Do you ship to my state, and which pharmacy license covers it? What is the all-in price at 7.5, 10, 12.5 and 15 mg? What is the price from month two, and does it change at renewal? Will my dosing instructions state the concentration of the vial you actually ship, and will you reissue them if it changes? A provider that answers all of these promptly is operating in the open; one that will not name its pharmacy has answered the most important question.
What works
Frequently cited among low-cost compounded providers. All-in monthly pricing.
What to weigh against it
Pricing pending verification. Limited public information about clinical model and pharmacies.
Who should choose Fifty 410
Price-focused patients comparing low-cost compounded plans. A patient with insurance coverage for Zepbound or Wegovy should compare the copay route first; a patient who wants a verified flat all-in price with month-to-month flexibility should compare the best overall provider on our value score; and any patient should ask which pharmacy fills the prescription before paying.
How we verified this
Fifty 410's pricing pages show a three-month tirzepatide starter of $399 ($133 per month equivalent) with higher-dose bundles priced separately and a four-week option of about $299, and semaglutide at $199 monthly; help content names ProRx and BPI/The Pharmacy Hub as 503A partners. State coverage not published in full. Verified against the provider's own pages on 2026-08-25 (first-party verification pass).